VBEF 2024 Future Healthcare Ecological Fair: Discussing the Path Forward for China's Innovative Pharma
We know that,
China has become the world’s second-largest pharmaceutical R&D power, with its drug pipeline ranking second globally. This has been accompanied by severe pipeline homogenization, overcapacity, and intense internal competition.
We observe that,
Chinese innovative drugs have begun to make their mark on the global market, and business development (BD) for these drugs is accelerating rapidly; however, the sector also faces challenges such as a sharp decline in IPOs, cooling investor interest, and elevated valuations.
Therefore, weTen Questions on Innovative Drugs, looking forward to finding answers at this year's forum!
The Era of Business Development for Innovative Drugs: How Can China’s Pipeline Attract Multinational Corporations?
Blindly Going Global or Strategically Landing: Where Should China’s Innovative Drugs Head Next?
A Trillion-Yuan Market Amidst Fierce Competition: What Lies Ahead for Peptide Drugs?
Breaking Out of the Red Ocean: How to Build a GLP-1 with Global Competitive Differentiation?
China’s Pharmaceutical CRO Sector: How to Achieve Differentiated Competition and Practice Amid Intensifying Involution?
Reshaping Business Logic and Cross-Application: New Expectations for mRNA Therapies?
The Rise of Domestically Produced Small Nucleic Acid Drugs: How Are They Leading the Third Wave of Modern Pharmaceutical Innovation?
The Dilemma of Pharmaceutical Marketing: Can Digitalization Be the Solution?
How Can CGT Advance Rapidly Amidst Challenges in the New Landscape?
How Much Spark Can Generative AI and Drug Discovery Generate?
Top 100 Innovative Pharmaceuticals and Biologics List
Annual Biopharmaceutical Investment Institution
Best Customer Satisfaction Pharmaceutical CRO
Top-Rated Pharmaceutical CDMO for Customer Satisfaction
Hengrui Medicine
Fosun Pharma
Shanghai Pharmaceuticals
Huahai Pharmaceutical
WuXi AppTec
Tigermed
Asymchem
Pharmablock Sciences
Joinn Laboratories
Pfizer
AbbVie
Novartis
Merck & Co.
BMS
AstraZeneca
Takeda Pharmaceutical
Novo Nordisk
Bayer
Merck
CSPC
Tasly
Baiyang Pharmaceutical Group
Aotai Kang Medicine
Beijing Hope Pharmaceutical
Tianjin Pharmaceutical Group
Riyue Tiancheng Pharmaceutical
China Medicine
Langzhi Pharmaceutical Group
Hanshu Biopharma
Yahong Medicine
Yanghe Biopharmaceuticals
Taikun Pharma
Baoli Yongchang Pharmaceutical
Kejite Pharmaceutical
Viatris
Paracen Biopharmaceuticals
Grand Pharma
Lingzheng Pharma
Tuoai Pharma
Yuanxing Pharma
Xinannuo Pharmaceutical
Shanghai Medicilon Biopharma
Aurive Bio
Asymchem Laboratories
Wuzhong Biopharmaceuticals
Kang En Bei Pharmaceutical
Baicheng Medicine
Qiantuhui Pharma
Trident Medicine
Shanghai Yibang Pharmaceutical
iCreate
Tasly Pharmaceutical
NeoNest Biopharmaceuticals
MedSci
Tiandao Medicine
Ocugen Biotech
Baishi Pharmaceutical
Aisituokang Pharmaceuticals
METiS Pharmaceuticals
China Resources Pharmaceutical
Jingrui Tianhe Pharmaceutical
Jian'an Medicine
Organon Pharmaceuticals
Liyou Pharmaceutical
Biopharmaceuticals
Nuoyu Pharma
Shanghai Biopharmaceuticals
Fangteng Pharma
BaiAo Pharma
Labcorp
Huadong Medicine
Bifang Pharma
Taiyuan Pharmaceutical
Xiuzheng Pharmaceutical
Shaanxi Licai Pharmaceutical
Salubris Pharmaceuticals
Beijing Tri-Prime Gene Pharmaceutical Co., Ltd.
Yabao Pharmaceutical
GenSci Pharmaceutical
CMS Pharmaceutical
Jichuan Pharmaceutical
Suzhong Pharmaceutical
Xinte Pharmaceutical
Meizilin Pharmaceutical
Beilu Pharmaceutical
Junxin Pharmaceutical
Sailin Pharmaceutical
Zhenbaodao Pharmaceutical
Longhua Pharmaceutical
Hongri Pharmaceutical
Yuheng Pharmaceutical
MicuRx Pharmaceuticals
Chia Tai Tianqing
Abogen Biosciences
XtalPi
Insilico Medicine
Belief Medicine
Zhongyi Anke
BioMap
Xuanzhu Biopharma
Haihe Pharmaceuticals
MTI Pharmaceuticals
IDVI Biologics
Tian Guangshi
Wuhan HealthGene Biotech
Reindeer Bio
Aikobio
Ribo Life Science
Yinli Pharmaceuticals
Fujian Gene
Shenxin Bio
Qingsai Biotech
Xiantong Medicine
Shengsi Biotech
GenFleet Therapeutics
TyMab
Zhongsheng Ruichuang
Xianweida Bio
Mingming Biology
Hangzhou Jiayin Biotech
Yinnuo Pharma
PegBio
Changfeng Pharmaceutical
Suoyuan Biopharma
Shanghai Hua'ao Tai
Baiming XinKang
MicroCon Biologics
Pumice Biologics
Blue Magpie Biotech
Shengnuoji
Aimabio
Bokang Vision Cloud
Jiachen West Sea
InnoMed Pharmaceuticals
Tagri
TaoLue Bio
True Biology
Chengyi Biologics
Hemei Pharmaceutical
Linker Pharmaceuticals
VizLivo
ImmuneOnco
KBP Biosciences
Heyuan Biologics
XuNuo Pharmaceuticals
Lupeng Pharmaceutical
EdiGene
Tongyuan Kang Pharmaceutical
Huahui Anjian
Huidagene
Kunpeng Bio
Triassic
Xinhe Biotech
New Element Pharma
AnjiSheng Bio
Jingze Biotech
Qihan Biotech
Yilian Bio
BeiHai Bio
Inflammation Biology
Changtai Pharmaceutical
Huadao Biology
Haichang Bio
Zesheng Technology
VCBeat
Hengmei Health
Gusen Pharma
Luoyi Biotech
Libang Pharma
Shengyin Biotech
Gebo Biotech
Magpie Pharma
Bowang Pharmaceuticals
Unknown君
Hode Bio
Katie Medical
Bangyao Bio
Affinity
Weimu Bio
Qinhao Pharma
Zhongsheng Suyuan
Zehui Bio
Minovate Pharma
Puruijin
Andao Pharmaceutical
Dingchi Biotech
Eglin Pharma
West Lake Biology
Kunli Biotech
Viva Biotech
Bosunji
Duality Biologics
Westlake Pharmaceutical
DanoMed
Swipe down to view the list of participating biopharmaceutical companies (partial)
Pharmaceutical Company Digital R&D Forum
May 8, 09:00–12:00
Forum on the Global Expansion of Original Medical Technologies
May 8, 09:00–12:00
Co-organized by: Boyuan Capital
Forum on the Innovative Development of the Synthetic Biology Industry
May 8, 13:30-17:20
Co-organized by: BIOINN, CAS Incubation
Innovative Development of the Peptide Drug Industry Chain
May 8, 13:30–16:40
Co-organized by: BlueRun Ventures
Anti-Aging Innovation Development Forum
May 9, 09:00–12:00
Supporting Organizations:Mingfeng Capital
RNA Forum
May 9, 09:00-12:00
Co-organized by: Xingcheng Biotech, VB New Medicine
Supporting Institutions: Panlin Capital, Fosun Health Capital
CGT Forum
May 9, 13:30–17:00
Supporting Institutions: Panlin Capital, Fosun Health Capital
Pharmaceutical Enterprise Digital Marketing Forum
May 9, 13:30–16:30
Indonesia-Focused Matchmaking Session for Overseas Expansion
May 9, 13:30–18:00
Co-organized by: PT Lumina ProCare Meditech
Co-sponsor：PT Lumina ProCare Meditech
2024 VBEF Future Healthcare Innovation Project Roadshow
May 8, 09:00-12:10
VBEF Healthcare Innovation Product Launch Event
Innovation Power Product Awards Ceremony
May 9, 13:30–16:30
Launch Event for Outstanding Scientific Research and Innovation Achievements from Chinese Universities
May 10, 09:30-15:15
Supporting Organizations:Peking University Third Hospital Innovation and Translation Center, Peking University Shanghai Lingang International Science and Technology Innovation Center, Nest.Bio, Southeast University Suzhou Medical Device Research Institute, National Engineering Research Center for Individualized Diagnosis and Treatment Technologies (Xiangya), “Regional TT0” Platform, Songshan Lake Materials Laboratory, BIOINN (Incubated by Chinese Academy of Sciences), Baidu Ventures, Beihang Tianhui, Beihang Investment, Proxima Venture Partners, Danlu Capital, Legend Capital, Shuimu Ventures, Yuanhe Yuandian, Yuanyi Capital, CAS Star, and Ruixi Innovation
If you have needs for connecting with innovative enterprises, innovative projects, or cooperative resources in the pharmaceutical sector, you are welcome to register for the “VBEF Pharmaceutical Innovation Project Investment and Financing Matchmaking Event,” scheduled from 16:00 to 20:00 on May 8. Participation is subject to approval, with limited slots available. Upon successful review by the organizer, you will be contacted via phone, WeChat, or other means for confirmation.
Scan the QR code to register
The 8th Future Healthcare Top 100 Conference has now been upgraded to the VBEF Future Healthcare Ecosystem Expo, which will be held inMay 7–10, 2024InBeijing · Beiren Yichuang International Exhibition CenterGrandly held. This edition of the exhibition is15,000+ visits; 10,000 sqm, focusing on new products and new technologies,New services, a new ecosystem, and new partnerships form an integrated system, complemented by the VBEF channel launched on the VCBeat app, creating the premier stage for showcasing innovation in the healthcare industry.
Here is,
Here it is,
The Most Influential List Released:Listed Companies’ Innovation Ranking + Future Healthcare 100 Ranking + Innovative Products Ranking, with 700+ listed companies engaging in on-site exchanges!
Currently, there areMore than 600 companies and products have confirmed their participation in the exhibition, with over 70% of the exhibition space already booked., the global buyer team has collaborated withIndonesia, Singapore, Belgium, Ireland, Spain, Germany, Australia, the United Kingdom, Canada, and other countries. Few partnership slots remain; enterprises, brands, buyer groups, and related organizations are welcome to negotiate attendance.
During the conference, download the VCBeat app and access the VBEF channel to obtain real-time updates on keynote speeches, link to online exhibition resources, and instantly connect with companies featured on the authoritative VBEF rankings.
In this era of uncertainty, seeking high-value resources and efficient connections will be your top choice.
Sign Up Now – Limited-Time Offer!